PTEN and cancer: Strong evidence derived from these GEMM-based studies demonstrates that miR-22 is a crucial driver in promoting cancer development and aggressiveness, by targeting and inhibiting tumor-suppressor genes, such as PTEN and TET (Ten eleven translocation) methylcytosine dioxygenase family members, thus upregulating cancer-associated pathways [11,29,30] (Figure 2).